GlycoMimetics - 53 Year Dividend History | GLYC
Historical dividend payout and yield for GlycoMimetics (GLYC) since 1971. The current TTM dividend payout for GlycoMimetics (GLYC) as of April 18, 2024 is $0.00. The current dividend yield for GlycoMimetics as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.139B |
$0.000B |
|
GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
